472 related articles for article (PubMed ID: 9200357)
1. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
[TBL] [Abstract][Full Text] [Related]
2. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
4. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome.
Bloom BT; Clark RH;
Pediatrics; 2005 Aug; 116(2):392-9. PubMed ID: 16061594
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
[TBL] [Abstract][Full Text] [Related]
7. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
Ramanathan R; Rasmussen MR; Gerstmann DR; Finer N; Sekar K;
Am J Perinatol; 2004 Apr; 21(3):109-19. PubMed ID: 15085492
[TBL] [Abstract][Full Text] [Related]
8. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
9. Calfactant: a review of its use in neonatal respiratory distress syndrome.
Onrust SV; Dooley M; Goa KL
Paediatr Drugs; 1999; 1(3):219-43. PubMed ID: 10937453
[TBL] [Abstract][Full Text] [Related]
10. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
[TBL] [Abstract][Full Text] [Related]
11. Exogenous surfactant use in neonates.
Ishisaka DY
Ann Pharmacother; 1996 Apr; 30(4):389-98. PubMed ID: 8729894
[TBL] [Abstract][Full Text] [Related]
12. High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome.
Kattwinkel J; Bloom BT; Delmore P; Glick C; Brown D; Lopez S; Willett L; Egan EA; Conaway M; Patrie J
Pediatrics; 2000 Aug; 106(2 Pt 1):282-8. PubMed ID: 10920152
[TBL] [Abstract][Full Text] [Related]
13. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
Horbar JD; Wright LL; Soll RF; Wright EC; Fanaroff AA; Korones SB; Shankaran S; Oh W; Fletcher BD; Bauer CR
J Pediatr; 1993 Nov; 123(5):757-66. PubMed ID: 8229487
[TBL] [Abstract][Full Text] [Related]
14. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome.
Zola EM; Gunkel JH; Chan RK; Lim MO; Knox I; Feldman BH; Denson SE; Stonestreet BS; Mitchell BR; Wyza MM
J Pediatr; 1993 Mar; 122(3):453-9. PubMed ID: 8441105
[TBL] [Abstract][Full Text] [Related]
16. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
Halliday HL
Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
[TBL] [Abstract][Full Text] [Related]
17. Goat lung surfactant for treatment of respiratory distress syndrome among preterm neonates: a multi-site randomized non-inferiority trial.
Jain K; Nangia S; Ballambattu VB; Sundaram V; Sankar MJ; Ramji S; Vishnubhatla S; Thukral A; Gupta YK; Plakkal N; Sundaram M; Jajoo M; Kumar P; Jayaraman K; Jain A; Saili A; Murugesan A; Chawla D; Murki S; Nanavati R; Rao S; Vaidya U; Mehta A; Arora K; Mondkar J; Arya S; Bahl M; Utture A; Manerkar S; Bhat SR; Parikh T; Kumar M; Bajpai A; Sivanandan S; Dhawan PK; Vishwakarma G; Bangera S; Kumar S; Gopalakrishnan S; Jindal A; Natarajan CK; Saini A; Karunanidhi S; Malik M; Narang P; Kaur G; Yadav CP; Deorari A; Paul VK; Agarwal R
J Perinatol; 2019 Sep; 39(Suppl 1):3-12. PubMed ID: 31485014
[TBL] [Abstract][Full Text] [Related]
18. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
Sehgal SS; Ewing CK; Richards T; Taeusch HW
J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
[TBL] [Abstract][Full Text] [Related]
19. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
[TBL] [Abstract][Full Text] [Related]
20. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll RF; Wiswell T
Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
